etravirine

FDA Drug Profile — Intelence, Etravirine, etravirine

Drug Details

Generic Name
etravirine
Brand Names
Intelence, Etravirine, etravirine
Application Number
NDA022187
Sponsor
Janssen Products LP
NDC Codes
12
Dosage Forms
TABLET
Routes
ORAL
Active Ingredients
ETRAVIRINE

Indications and Usage

1 INDICATIONS AND USAGE Etravirine, in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in antiretroviral treatment-experienced adult patients and pediatric patients 2 years of age and older [see Microbiology (12.4) and Clinical Studies (14) ] . Etravirine is a human immunodeficiency virus type 1 (HIV-1) non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated for treatment of HIV-1 infection in treatment-experienced patients 2 years of age and older. ( 1 )